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Abstract
Purpose Personality traits appear as determinants of
quality of life (QoL) in most chronic diseases. The aim of
this study is to explore whether neuroticism and extraver-
sion contribute to the variance in QoL in patients with
Parkinson’s disease (PD) when controlled for age, func-
tional status and disease duration.
Methods The Parkinson’s Disease Quality of Life Ques-
tionnaire (PDQ-39) was used to assess QoL and the Unified
Parkinson’s Disease Rating Scale (UPDRS) for disease
severity. Neuroticism and extraversion were measured with
the Eysenck Personality Questionnaire (EPQR-A). Multi-
ple linear regression analysis was then used to assess the
contribution of neuroticism and extraversion to QoL.
Results The sample consisted of 153 PD patients (48.4%
women; 67.9 ± 9.3 years; mean disease duration 7.5 ±
5.8 years). Neuroticism was, after disease severity, the
second most important variable associated with QoL in
PD patients, in particular for domains associated with
psychological processes: emotional well-being, social
support, stigma and communication. A higher score in
extraversion was significantly associated with better emo-
tional well-being in males, but surprisingly, with worse
emotional well-being in females.
Conclusions After functional status, personality traits
were clearly associated with QoL in PD patients. There-
fore, they should be taken into account by health-care
professionals in their appraisal of patient complaints.
Keywords Parkinson’s disease  Extraversion 
Neuroticism  Quality of life  Gender
Introduction
Parkinson’s disease (PD) is a progressive neurodegenera-
tive disease that affects 1% of all people over 60 years of
age and around 2% of the population over 80 years of age.
It includes both physical and mental symptoms that have
an impact on the quality of life (QoL) of those with the
disease [1, 2]. The physical symptoms of PD typically
affecting QoL are tremor, rigidity, slowness, a blank stare
(the so-called ‘‘Parkinson’s mask’’) and troubles with
manual dexterity [3]. Mental symptoms may include
depression, sleep disorders, hallucinations and delirium,
some of which may be related to therapy using dopami-
nergic drugs [4, 5]. The social components of PD involve
isolation due to the embarrassment caused by the symp-
toms and problems with communication [6].
With regard to basic sociodemographic and clinical
variables, increasing age and higher disease duration have
been found to be associated with decreased QoL in PD
patients [7]. In addition, mildly significant differences in
disability and QoL have been noted between the genders in
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general: women have reported greater disability and
reduction of QoL than men [8]. Gender differences are also
present in the incidence of PD: the disease occurs more
frequently in men than in women in every decade of life
[9]. One of the various theories explaining these differ-
ences is that they may result from the neuroprotective
effects of estrogen [8, 10, 11].
Some personality traits, such as neuroticism and extra-
version, are assumed to be factors that contribute to the
perception of health status and thus lead to a worse per-
ception of QoL by people with several chronic diseases
[12–14]. People who score high on the neuroticism scale
manifest more worries, uncertainties and anxiety [15].
Because these people are more likely to behave overly
emotionally and react too strongly to all sorts of stimuli,
their neuroticism seems to be associated with psychologi-
cal dysfunction [15, 16]. Some authors have reported that
neuroticism also appears to be associated with the tendency
to recall physical symptoms as being worse than they really
were [17, 18], thus indirectly contributing to a lower per-
ceived QoL [19]. Quality of life of patients with chronic
diseases may also be influenced indirectly by extraversion.
Extravertly oriented people have a tendency to be sociable
and to prefer changes, and there is a high probability that
they will crave excitement and act impulsively [15]. It has
been observed that people with a low score in extraversion
are more self-centered and are more sensitive to stress than
extraverted people [20]. Therefore, it might be hypothe-
sized that extraversion influences the level of coping with
chronic disease and can thus also influence the level of
QoL [20, 21].
The QoL of patients with PD is frequently studied, but
very little is known about the associations between per-
sonality traits and QoL in these patients. The aim of this
study, therefore, is to explore whether personality traits
(neuroticism and extraversion) contribute to the variance in
QoL in patients with PD when controlled for disease
severity, disease duration and age. In addition, this study
analyzes whether gender differences in the QoL of PD
patients can be attributed to gender-related differences in
extraversion and neuroticism in these patients.
Methods
Subjects and procedure
Data collection took place between February 2004 and
February 2006. One hospital in Bratislava as well as 4
hospitals and 17 outpatient neurology clinics in the eastern
part of the Slovak Republic cooperated in this study.
Questionnaires were sent to patients diagnosed with
Parkinson’s disease 3 weeks before the interview. All
patients were diagnosed according to the United Kingdom
Parkinson’s Disease Society Brain Clinical Criteria [22].
Exclusion criteria were defined as follows: (1) patients
older than 85 years because of the high probability of other
co-morbidities and movement disabilities of a non-par-
kinsonian character and (b) an MMSE score lower than 23
points.
An interview with each patient took place 3 weeks after
the invitation. After each interview, a neurologist assessed
the severity of the patient’s disease using the Unified
Parkinson’s Disease Rating Scale (UPDRS Version 3.0)
[23]. The patients’ mental status was assessed with the
Mini-Mental State Examination (MMSE) [24]. The struc-
tured interview consisted of questions about the patient’s
medical history and subjective feelings that were not part
of the questionnaire. Sociodemographic data were derived
from medical records and from questionnaires filled in by
the patients themselves.
The study was conducted after informed consent was
obtained from the patients prior to the study. The local
Ethics Committee of the University Hospital in Kosice
approved the study in Kosice on 17 December 2002.
Measures
Disease severity
The Unified Parkinson’s Disease Rating Scale (UPDRS) is
currently used as a standard reference scale in clinical
practice and in research for assessing disease severity in
patients with PD. Ratings are observation-based, and scores
are obtained by interview and physical examination. The
scale consists of four parts: mentation and mood (part 1),
activities of daily living (part 2), motor function (part 3)
and complications resulting from dopaminergic therapy,
including motor fluctuations and dyskinesias (part 4). Parts
1, 2 and 4 are interview-based, while part 3 is based on a
clinical examination by a health professional and repre-
sents the patient’s condition at the time of the examination.
Patients can score from 0 to 176, with higher scores indi-
cating increased disease severity [23].
Extraversion and neuroticism
The Eysenck Personality Questionnaire Revised Abbrevi-
ated (EPQR-A) was used for measuring Extraversion and
Neuroticism [25]. The questionnaire was validated in the
Czech Republic in a sample of 3,565 people [26]. The
Slovak and Czech languages are similar, and today’s Czech
and Slovak Republics were, prior to 1993, united in a
single country. Thus, results from the Czech Republic
could be valid also for the needs of this research. The
questionnaire consists of 24 items divided into 4 subscales:
34 Qual Life Res (2009) 18:33–42
123
extraversion, neuroticism, psychoticism and the lie scale.
Items are scored on a Yes (=1) No (=0) basis, and the
overall score for each subscale ranges from between 0 and
6, with higher scores indicating higher levels for the per-
sonality traits. Internal reliability found across the samples
was .74–.84 for the extraversion subscale and .70–.77 for
neuroticism [27]. In the present study, Cronbach’s alpha
was .85 for extraversion and .72 for neuroticism.
Quality of life
The Parkinson’s Disease Questionnaire—long form
(PDQ-39) is a disease-specific instrument developed for
measuring health-related quality of life in patients with
Parkinson’s disease. Its 39 items are divided into 8 scales:
mobility (10 items), activities of daily living (6 items),
emotional well-being (6 items), stigma (4 items), social
support (3 items), cognition (4 items), communication (3
items) and bodily discomfort (3 items). In response to each
question, respondents select from answers ranging from
never (0), occasionally (1), sometimes (2), often (3) and
always (4). Each scale and the summary index were
transformed in order to have a range from 0 (= no problem
at all) to 100 (= maximum level of a problem) [28]. We
translated the questionnaire from its original source [28]
into the Slovak language and then translated it back into
English using another translator. Two Slovak native
speakers with mastery of the English language first trans-
lated the questionnaires from English into Slovak. The
questionnaires were then re-translated from Slovak back
into English, this time by a native English speaker with
mastery of the Slovak language. The discrepancies between
the different versions of the questionnaires were then dis-
cussed. We checked the basic psychometric characteristics
of the scale, but these have not yet been published. In the
present study, the Cronbach’s alphas were as follows: .93
(mobility), .91 (activities of daily living), .85 (emotional
well-being), .88 (stigma), .75 (social support), .67 (cogni-
tion), .76 (communication) and .80 (bodily discomfort).
Statistical analysis
The Statistical Package for the Social Sciences (SPSS
14.0.1.) software was used to analyze the data. Firstly,
independent sample t-tests were conducted to assess dif-
ferences between the genders in disease severity, age,
disease duration, extraversion and neuroticism. As a second
step, a difference of proportions test (CIA) was used to
assess gender differences in partnership and education [29].
Thirdly, Pearson’s correlation coefficients were used to
determine the strengths of the relationships between the
study variables. Finally, multiple linear regression analyses
were used to assess the contribution of the independent
variables age, gender, disease duration, functional status
(UPDRS) and personality traits (E and N) and to explain
the variance of the dependent variables—the dimensions of
the PDQ-39. Identical multiple linear regression analysis
was performed for males and females separately.
Results
Out of 512 patients with Parkinson’s disease, 160 agreed to
participate and filled in the questionnaires. Forty-one of the
512 refused to participate, and 311 did not respond to the
invitation. Seven patients were excluded after the personal
interview because of the exclusion criteria. The final
sample consisted of 153 patients (response rate 31.3%).
Non-respondents differed significantly from the analyzed
group in age (mean difference 1.69 years, SE = .87; t = -
1.95; 95% CI .010 to -3.39), and there were significantly
more women than men among the non-respondents (dif-
ference -.0110; SE = .041; 95% CI -.091–.069).
Descriptive statistics
Females made up 48.6% of the participants and males
51.4%, with a mean age of 67.9 ± 9.3 years (range 44–
83). The mean disease duration was 7.5 ± 5.8 years (range
0–34). One hundred and four patients from the sample
(68%) lived with a partner, and 49 patients (32%) were
widowed, divorced or single. Fifty-two patients (34%) had
completed elementary education, 84 patients (55%) sec-
ondary education and 17 patients (11%) had a university
education. Disease severity in the patients varied from 5
points to 97, with a mean score (38.8) on the UPDRS
representing medium disease severity.
All patients used antiparkinsonian therapy according to
international guidelines [30, 31].
Gender differences in the study variables
Males and females did not differ in age, disease duration
and disease severity. No differences between genders were
found with regard to the psychological variables extraver-
sion and neuroticism. There were no differences between
genders in the scores of the overall QoL and in PDQ-39
dimensions, except for bodily discomfort (P = .05), where
women scored significantly higher (Table 1).
Results of correlation analyses
Table 2 presents the correlations between the PDQ-39 and
age, disease duration, disease severity, extraversion and
neuroticism for males and females separately. Disease
severity significantly correlated with all scales of the
Qual Life Res (2009) 18:33–42 35
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PDQ-39, except for satisfaction with social support in men.
In women it played a less important role.
Examining the relationships between variables by means
of Pearson’s coefficients showed significant correlations
between extraversion on one hand and mobility and activ-
ities of daily living on the other. Females with higher scores
for extraversion reported better QoL in the dimension of
activities of daily living, in contrast to males, for whom
extraversion did not appear to be important for any of the
study variables.
The correlations show a strong relationship between
nearly every sub-scale of PDQ-39 and neuroticism. For
females, neuroticism is the main variable correlating with
the QoL scales.
Overall QoL, represented by the PDQ-39 summary
index, correlated with disease severity in both genders. In
females it also correlated with neuroticism and in males
with disease duration.
Model of predictors of QoL
Multiple linear regression analyses were performed in order
to identify how much the variance of the dependent vari-
ables (mobility, activities of daily living, emotional well-
being, stigma, social support, cognition, communication
and bodily discomfort) could be explained by the person-
ality traits if controlled for the relevant sociodemographic
and clinical variables (Table 3). Table 3 (and also Table 4)
shows the beta values, which reveal the relationships
between the dimension and each value in the model. The
standardized beta values were all measured in standard
deviation units and so are directly comparable; e.g., a beta
of 0.78 means that increases of 1 point on the UPDRS total
score are associated with an increase of .78 point on the
ADL scale.
The analyses were controlled for both disease variables
(disease severity and disease duration) and for age. Higher
age predicted worse scores in the subscales cognition and
communication. Disease duration explained some of the
variance, but only in communication. As expected, disease
severity was the strongest predictor in almost all dimen-
sions of PDQ-39, particularly in activities of daily living,
mobility, emotional well-being, cognition, communication
and bodily discomfort, but it did not appear to be associated
with the dimensions of social support and stigmatization.
The model for overall QoL was fully covered only by
disease severity and neuroticism. Extraversion appeared to
be a significant factor only for the dimension communi-
cation. Neuroticism was important mostly in the domains
that are associated with some kind of psychological pro-
cesses: emotional well-being, stigma, social support and
communication. However, neuroticism also explained
some of the variance in activities of daily living and bodily
discomfort.
Table 1 Characteristics of the sample—percentages, means and standard deviations (SD) of study variables
Males Females Total sample t-tests/CIA
Number of subjects (%) 79 (51.6) 74 (48.4) 153 (100)
Mean age in years (SD) 68.5 (9.2) 67.3 (9.3) 67.9 (9.3) ns
Mean disease duration in years (SD) 7.7 (5.7) 7.4 (5.8) 7.5 (5.8) ns
Disease severity—UPDRS (SD) 38.8 (22.2) 34.9 (18.7) 36.9 (20.6) ns
Married or living with a partner (%) 66 (83.5) 38 (51.4) 104 (68)
Education
Elementary (%) 22 (27.8) 30 (40.5) 52 (34)
Secondary (%) 44 (55.7) 40 (54.1) 84 (55)
University (%) 13 (16.5) 4 (5.4) 17 (11)
Quality of life—PDQ-39 total (SD) 56.9 (17.4) 61.2 (16.4) 58.9 (17.0) ns
Mobility (SD) 60.2 (25.0) 66.4 (23.4) 63.2 (24.4) ns
Activities of daily living (SD) 58.2 (26.0) 57.5 (27.3) 57.9 (26.6) ns
Emotional well-being (SD) 59.9 (20.6) 65.5 (19.8) 62.6 (20.4) ns
Stigma (SD) 53.7 (25.0) 54.5 (27.3) 54.1 (26.0) ns
Social support (SD) 38.8 (18.0) 42.2 (20.7) 40.4 (19.4) ns
Cognition (SD) 57.2 (20.1) 60.6 (18.6) 58.9 (19.4) ns
Communication (SD) 49.9 (21.4) 48.9 (20.3) 49.4 (22.6) ns
Bodily discomfort (SD) 69.7 (23.5) 80.9 (20.2) 75.2 (22.6) t B 0.05
Extraversion (SD) 2.7 (2.2) 2.7 (2.3) 2.7 (2.2) ns
Neuroticism (SD) 2.1 (1.8) 2.7 (1.9) 2.4 (1.9) ns
Abbreviations: SD, standard deviation; ns, non-significant
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Gender differences in predictors of QoL
Table 4 presents the results of multiple linear regression
analyses for men and women separately. Significant gender
differences were found in the predictors of the PDQ-39
sub-scales and for its summary index.
Out of all sociodemographic variables, only age
appeared to contribute significantly to the total explained
variance. Lower age was significantly associated with
stigmatization by illness and social support in women.
Higher age was closely connected with lower scores in the
domains cognition and communication in men. Disease
duration had an impact on QoL only in the cognition
subscale in men. Functional status was the only factor of
the domains mobility, activities of daily living and emo-
tional well-being in both genders. In males it also had an
impact on communication and bodily discomfort, whereas
in females it was connected with worse cognition.
Overall QoL was associated in both genders with dis-
ease severity and neuroticism. In men, 3.3% of the variance
was also explained by extraversion. Extraversion explained
4.7% variance in communication in men and 6.4% in
women. For both genders extraversion was an important
part of the model of emotional well-being, though the
observed relations were in the opposite direction. In
women a high score for extraversion was associated with
lower QoL in emotional well-being, whereas in men a
higher score in extraversion was associated with a better
score in this dimension. Neuroticism played an important
role in emotional well-being and social support in both
genders. In women neuroticism was also associated with
stigmatization by illness and bodily discomfort.
Discussion
The aim of this study was to explore the contribution of
personality traits (neuroticism and extraversion) to QoL in
patients with PD and the contribution of possible gender
differences in extraversion and neuroticism to QoL.
Disability, as expected, was the fundamental variable for
QoL. In the intercorrelations between the variables, asso-
ciations were found between disease duration and all PDQ-
39 scales in men, but none in women. However, disease
duration did not significantly contribute to the models for
each scale, except cognition in men. In addition to disease
severity, the second most important factor for QoL in PD
patients was neuroticism. Patients with higher scores on the
neuroticism scale reported significantly worse status in the
domains of emotional well-being, stigma, social support
and bodily discomfort. However, in separate models for
males and females, neuroticism remained important only in
the subscale of emotional well-being in both genders.
Neuroticism played a role in the subscales of stigma and
social support in women, but it did not appear to be
important in men due to the low validity of the social
support model for men.
Our results for neuroticism correspond with studies
focusing on other patient groups, including patients with
cognitive impairments, chronic pain and depression. A
high level of neuroticism predicts the use of ineffective
passive coping strategies, and those patients reported worse
perception of their health problems [32–34]. It seems that
because of societal influences, males and females develop
different ways of coping and experiencing the world [34].
This phenomenon was also found by researchers who
observed that a different score in neuroticism reflects
socially learned behavior rather than biological differences.
Gender-role rather than gender had greater explanatory
power with regard to neuroticism [35].
Extraversion was associated only with the subscale of
communication: patients scoring higher on the extraversion
scale seem to have fewer problems with communication
skills. This corresponds with the study by Eysenck (1991)
[15], where to be talkative is one of the characteristics of an
extravertly oriented person. However, there were differ-
ences between males and females in the model of
emotional well-being. For both genders, extraversion is an
important variable, but in the opposite direction. Extra-
verted males perceived their emotional well-being as
better, but a higher score in extraversion was associated
with worse emotional well-being in females. An explana-
tion might be the associations between extraversion and
coping strategies that have been found in several studies
[20, 21]. These differences could be explained by the
supposed use of different coping strategies by males and
females [36]. Our results support the findings of one
Spanish study, which confirmed a close association
between extraversion and active coping strategies, which
are used mostly by males [20].
Analysis presented in this article explains only part of
the variance in the QoL of patients with PD. The construct
of QoL of those patients appears to be too complicated to
be explained by psychological variables such as personality
traits. Models of stigma, social support, cognition and
bodily discomfort were significant in general, but the
adjusted R2 explains only a relatively small part of the
variance. However, the relationships between study vari-
ables and these dimensions are significant. Differences in
the significance between models for men and women
suggest possible differences in the model variables. It can
be hypothesized that models of QoL for men and women,
especially in the dimensions stigma, social support, cog-
nition and bodily discomfort, are composed from different
variables. The gender aspect of QoL appears to be an
important focus for further studies.
40 Qual Life Res (2009) 18:33–42
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A limitation of this study was the relatively low
response rate, which may have an impact on generaliza-
tions of the results to the total population of PD patients.
Non-respondents were older than respondents, so one
might hypothesize that they refused to participate in the
study because of serious motor complications in the
advanced stages of PD and because of an increased need
for help from their social surroundings. Regrettably, we
have no information about the disease duration and the
disease severity of the non-respondents.
Future research should concentrate on explaining how
PD patients cope with health problems. The impact of
personality traits on QoL is known from different studies
on several chronic diseases. For example, close associa-
tions between extraversion, neuroticism and mental
condition of the patients were confirmed in hemodialysis
patients [21]. However, in the field of PD this is a relatively
new idea.
Currently, the management of patients with PD is pri-
marily aimed at prolonging life expectancy and
diminishing motor disabilities [37]. The results of this
study show that psychological traits are clearly associated
with QoL as well and therefore should be taken into
account by health-care professionals in their appraisal of
patient complaints. PD patients with high scores in neu-
roticism, especially females, may be considered as a
population at risk for lower QoL.
Effective management of PD patients should include a
specific approach to improve QoL in the course of treatment.
Our results are important for neurologists; they could use
them in the phase of diagnosis where patients with higher
scores in neuroticism could aggravate their symptoms, and
also in the phase of the treatment where patients could differ
in their perception of the efficacy of the treatment.
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